It has been shown that high expression of CCL20 in breast cancer cells can potentiate the differentiation and expansion of granulocyte-monocyte progenitors into polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) via CCR6. Here, CCL20 is linked to breast carcinoma.